Health Medicine Network 2026: How Blocking a key receptor may curb immunotherapy-related liver damage
August 14, 2026
The lead investigators in a study published in Science Advances, Sergey A. Shein, PhD, a research instructor, and Alexei V. Tumanov, MD, PhD, an associate professor, at UT Health San Antonio, the academic health center and health system of The University of Texas at San Antonio, were quoted in this article. Read More
